The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak

Abstract

The SARS-CoV-2, a newly identified β-coronavirus, is the causative agent of the third large-scale pandemic from the last two decades. The outbreak started in December 2019 in Wuhan City, Hubei province in China. The patients presented clinical symptoms of dry cough, fever, dyspnea, and bilateral lung infiltrates on imaging. By February 2020, The World Health Organization (WHO) named the disease as Coronavirus Disease 2019 (COVID-19). The Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses (ICTV) recognized and designated this virus as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 uses the same host receptor, angiotensin-converting enzyme 2 (ACE2), used by SARS-CoV to infect humans. One hypothesis of SARSCoV-2 origin indicates that it is likely that bats serve as reservoir hosts for SARSCoV-2, being the intermediate host not yet determined. The predominant route of transmission of SARS-CoV-2 is from human to human. As of May 10th 2020, the number of worldwide confirmed COVID-19 cases is over 4 million, while the number of global deaths is around 279.000 people. The United States of America (USA) has the highest number of COVID-19 cases with over 1.3 million cases followed by Spain,

Role of eosinophils in the diagnosis and prognostic evaluation of COVID‐19

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen of COVID-19 and poses an unprecedented threat to human health as the number of infectious cases continue to rise rapidly in various countries. 1 After severe acute respiratory syndrome (SARS) and…”

Rapid point-of-care testing for SARS-CoV-2 virus nucleic acid detection by an isothermal and nonenzymatic Signal amplification system coupled with a lateral flow immunoassay strip

“…In December 2019, there was an outbreak of a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19) [ 1 , 2 ]. SARS-CoV-2 infection is a serious global public health issue that has caused serious economic losses worldwide, leading the World Health Organization to characterize the COVID-19 outbreak as a public health emergency of international concern.…”

In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect

“…The number of COVID-19 patients and death cases varied from a region to another [6]. In many countries, an important number of con rmed cases were reported, such as in the United States of America (USA), Brazil, India and Russia causing [6][7][8][9]. For instance, in the USA, more than eight million con rmed cases and two hundred thousand deaths were recorded until the 18 th of October 2020 [6,9].…”